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Abstract Two children underwent acute hemodialysis
using high-efficiency dialysis membranes for vancomy-
cin intoxication (plasma levels 238 µg/ml and 182 µg/ml).
During a 3-h treatment, plasma vancomycin removal was
on average 60%, with a calculated vancomycin half-life
(t1/2) of 2 h. This is in contrast to a recent report using
charcoal hemoperfusion for vancomycin intoxication
(plasma level of 137 µg/ml), which resulted in a 40% rel-
ative plasma clearance and a calculated vancomycin t1/2
of 12.5 h for a 4-h treatment. The choice of optimal mo-
dality for clearing a toxin should take into account the
availability of equipment, protein or lipid binding of the
toxin, and inherent risks of charcoal hemofiltration (large
extracorporeal circuit, reversible hypocalcemia, heat
loss, reversible coagulation defects) versus risks of high-
efficiency hemodialysis (large extracorporeal circuit).
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Introduction
Vancomycin, a commonly prescribed antibiotic in se-
verely ill children, is primarily excreted by the kidney
and can accumulate in a child with deteriorating renal
function. Vancomycin can be associated with ototoxicity
but, when combined with aminoglycosides, can be neph-
rotoxic [1].
Historically, vancomycin overdose was treated by
forced diuresis, due to its limited toxicity and limited
ways of removing the drug. The recent report by Pan-
zarino et al. [2] suggested the use of charcoal hemoper-
fusion for vancomycin overdose. Although charcoal
hemoperfusion is effective, it adds the increased risks as-
sociated with a large extracorporeal circuit volume,
namely associated heat loss, hypocalcemia, and possible
predisposition to a coagulative state [3].
The advent of high-efficiency dialysis membranes,
has resulted in improved vancomycin removal, with a
need for an increase in dosing frequency compared with
standard dialysis membranes [4, 5]. We recently had ex-
perience using high-efficiency dialysis membranes for
vancomycin overdose in two separate children. We re-
port this experience suggesting that it offers an alterna-
tive method to charcoal hemoperfusion.
Case reports
Case 1
Patient 1 is a 22-kg female with a liver transplant who was admit-
ted to hospital for central indwelling venous line sepsis and was
treated with vancomycin. Her renal function deteriorated due to
the sepsis, resulting in a vancomycin level of 345 µg/ml (normal
<40 µg/ml), oliguria, and a serum creatinine of 3.2 mg/dl; 36 h la-
ter, the Nephrology Service was consulted, and dialysis was insti-
tuted at a vancomycin level of 238 µg/ml. For comparison purpos-
es, the calculated vancomycin half-life (t1/2) was 67.2 h using the
method described by Panzarino et al. [2]. Access was obtained via
a femoral 9.0-Fr MedComp dual-lumen amless. A Baxter 550 he-
modialysis machine was used with a high-efficiency cellulose tri-
acetate dialysis membrane (CT 110 Travenol-Baxter Healthcare,
Deerfield, Ill., USA) and pediatric lines giving an extracorporeal
blood volume of 165 ml [6]. Blood flow was 5 ml/kg per min; du-
ration of treatment was 3 h and the potassium, phosphorus, and
calcium baths were adjusted according to the needs of the patient.
The post-run (3 h later) vancomycin level was 78 µg/ml, demon-
strating greater then 67% removal of the intravascular content of
vancomycin, or a calculated vancomycin t1/2 of 1.9 h. In the next
24 h, despite no further drug being given, the vancomycin level
had rebounded to 123 µg/ml, which is expected due to normal ki-
netics and pools of vancomycin [6]. A second dialysis treatment
decreased the vancomycin level to 54 µg/ml (calculated vancomy-
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cin t1/2 of 2.5 h). The next day, the vancomycin had rebounded to
74 µg/ml and a third hemodialysis treatment resulted in a post-run
level of 28 µg/ml (calculated vancomycin t1/2 of 2.2 h).
Case 2
Patient 2 is a 5.6-kg boy with obstructive uropathy and renal dys-
plasia who had urosepsis and was treated at an outside hospital
with vancomycin and gentamicin. Whereas the gentamicin was
adjusted, the vancomycin level was found to be 313 µg/ml with a
serum creatinine of 1.0 mg/dl and a calculated creatinine clearance
of 45 ml/min per 1.73 m2 by the Schwartz method [7]. He was
transferred with the request for charcoal hemoperfusion. Due to
his underlying renal dysplasia, he never had oliguria, and his cre-
atinine improved with hydration. Access was obtained via a femo-
ral 7.0-Fr Cook (Bunchman coaxial) dual-lumen amless. A Baxter
550 hemodialysis machine was used with a high-efficiency dialy-
sis membrane (CT 110 Travenol-Baxter Healthcare) and pediatric
lines giving an extracorporeal blood volume of 165 ml. Blood
flow was 12 ml/kg per min; duration of treatment was 3 h and the
potassium, phosphorus, and calcium baths were adjusted accord-
ing to the needs of the patient. The pre-run vancomycin level was
182 µg/ml (calculated vancomycin t1/2 of 31 h using his admission
vancomycin level) and the post-run level (3 h later) was 73 µg/ml,
suggesting greater then 60% removal of the intravascular content
of vancomycin, or a calculated vancomycin t1/2 of 2.3 h. A second
dialysis treatment decreased the vancomycin level from 63 µg/ml
to 37 µg/ml over 2 h (calculated vancomycin t1/2 of 3.9 h).
Discussion
Both of these patients demonstrated adequate removal of
vancomycin using a high-efficiency dialysis membrane.
The smallest high-efficiency dialysis membrane requires
an 80 ml blood volume, which requires blood priming in
the small pediatric patient. However in these two cases,
both children were blood primed. The patient with an in-
travascular blood volume of 1,400 ml, was blood primed
due to hemodynamic instability. The second child was
5.4 kg, and required blood priming of the circuit due to
the large extracorporeal blood volume [8]. Although the
dialysate rate is often increased from the standard
500 ml/min to as high as 800 ml/min in true high-flux di-
alysis, normal (500 ml/min) dialysate flow rates were
used in both of these patients.
Similar to charcoal hemoperfusion, both circuits in
this study had the added disadvantage of large extracor-
poreal blood volume requiring blood transfusions during
the time of therapy. In contrast to charcoal hemoperfu-
sion, the use of a high-efficiency dialysis membrane
does not have the added disadvantage or risk of remov-
ing calcium, inducing hypothermia, or thrombocytopenia
[3]. Although these risks associated with charcoal hemo-
perfusion are all predictable and preventable, these side
effects will not occur using a high-efficiency dialyzer.
The charcoal hemoperfusion circuit is classically
placed in line prior to the hemodialysis membrane in or-
der to normalize calcium and warm the blood prior to re-
turning the blood to the patient. Because the blood flow
is often increased in order to maximize toxin removal,
this higher rate of blood flow may not allow for com-
plete normalization of these potential complications of
charcoal hemoperfusion.
Panzarino et al. [2] identified a 40% relative removal
of vancomycin from the intravascular content during the
initial run. This is compared with our findings of 67%
and 60% removal during both initial treatments using a
high-efficiency dialysis membrane with treatment times
1 h shorter. Panzarino et al. [2] reported an initial t1/2
of 12.5 h for a 4-h treatment with an initial vancomy-
cin level of 137 µg/ml. We found a t1/2 of 1.9 h for an
initial level of 238 µg/ml and 2.3 for an initial level of
182 µg/ml, each of these treatments being over 3 h.
Therefore, the removal of vancomycin is effective with
high-efficiency dialysis membranes or charcoal hemo-
perfusion, but different techniques and flow rates do not
allow for a direct comparison of efficacy. The decision
of optimal modality may be influenced by whether or not
the drug is bound (e.g., lipid or protein) or free in plasma
[5].
Data to date do not adequately compare high-efficien-
cy dialysis membranes with continuous hemofiltration
for the treatment of intoxication [9]. Continuous hemo-
filtration has been found to effectively clear vancomycin,
but this depends upon blood flow rate, dialysate flow,
and the surface area and charge of the hemofilter mem-
brane. In conclusion, when approaching a child with a
drug overdose, one should consider high-efficiency dial-
ysis membranes as a primary therapy for clearing medi-
cations.
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